Randomized Clinical Trial for Comparison Of Intravenous Carbeitocin Versus Oxytocin In Management Of Placental Delivery In Second Trimester Interruption
NCT ID: NCT01827124
Last Updated: 2013-10-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
140 participants
INTERVENTIONAL
2013-04-30
2013-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
FACTORIAL
PREVENTION
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
carbetocin and placebo
100microgram carbetocin IV and 1cc normal saline(placebo)infusion
Carbetocin
oxytocin
oxytocin and placebo
20Interntional unit oxytocin infusion and 1cc normal saline IV
Carbetocin
oxytocin
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Carbetocin
oxytocin
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Pregnancy duration: 14-24weeks
* Spontaneous abortion or medical induced abortion at 14-24weeks
Exclusion Criteria
* Surgical termination
* Placenta previa
* Uterine fibroid
16 Years
50 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ain Shams Maternity Hospital
OTHER
Wafaa Uthman Ahmed
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Wafaa Uthman Ahmed
Ain shams university
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ain Shams university maternity hospital department of obstetrics and gynacology
Cairo, Tertiary, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Ahmed M Ibrahim, ass. prof
Role: primary
Mohamed SE El-safty 002, lecturer
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Ain Shams U
Identifier Type: -
Identifier Source: org_study_id